Editorial
Open access
Sep 2026
Co- and multipathologies need serious consideration for understanding Parkinson's disease pathogenesis and designing novel experimental therapeutic strategies
Investigation of anti-α -synuclein immunotherapy as a potential disease-modifying strategy for PD found no evidence of delay in motor progression and exploratory studies suggested potential clinical activity.
A. Boehringer, L. Kalia, B. Bloem et al.
· Journal of Parkinson's Disea... · 0 citations